CVS Health Corporation $CVS Shares Purchased by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System lifted its holdings in CVS Health Corporation (NYSE:CVS) by 14.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 78,768 shares of the pharmacy operator’s stock after purchasing an additional 10,199 shares during the quarter. Maryland State Retirement & Pension System’s holdings in CVS Health were worth $6,750,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Ritholtz Wealth Management raised its position in shares of CVS Health by 7.6% during the 3rd quarter. Ritholtz Wealth Management now owns 27,787 shares of the pharmacy operator’s stock valued at $2,381,000 after buying an additional 1,967 shares in the last quarter. Joel Isaacson & Co. LLC grew its position in CVS Health by 5.7% in the third quarter. Joel Isaacson & Co. LLC now owns 3,620 shares of the pharmacy operator’s stock worth $310,000 after acquiring an additional 195 shares in the last quarter. Altman Advisors Inc. purchased a new position in CVS Health in the third quarter worth about $1,978,000. Machina Capital S.A.S. bought a new stake in CVS Health during the third quarter worth approximately $846,000. Finally, Silver Grove Financial Group Inc. increased its stake in CVS Health by 17.8% during the third quarter. Silver Grove Financial Group Inc. now owns 1,270 shares of the pharmacy operator’s stock worth $109,000 after acquiring an additional 192 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Trending Headlines about CVS Health

These are some of the CVS headlines that stood out recently:

• Positive Sentiment: CVS reported quarterly adjusted earnings of $2.09 per share, beating the $1.65 consensus estimate, while revenue rose 5.4% year over year to $108.4 billion. The earnings beat and growth support the case for improved operating performance. Article: CVS Beat Earnings by 27% and Split in Two
• Positive Sentiment: CVS’s planned 2028 split could sharpen strategic focus and improve capital allocation, potentially unlocking value in its businesses. Wells Fargo kept an “overweight” rating and sees its $112 price target as implying upside, despite lowering the target from $123. Article: Can CVS Health’s 2028 Split Unlock Value Despite Execution Risks?
• Neutral Sentiment: Wells Fargo’s price-target cut signals more cautious valuation assumptions, though its continued overweight rating indicates the analyst remains positive on CVS. Article: Wells Fargo rating and price target

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Barclays decreased their price objective on CVS Health from $108.00 to $107.00 and set an “overweight” rating on the stock in a research report on Thursday, November 5th. Piper Sandler set a $112.00 target price on CVS Health in a report on Wednesday, September 9th. BMO Capital Markets set a $112.00 target price on CVS Health in a research report on Wednesday, September 9th. Wells Fargo & Company cut their target price on CVS Health from $123.00 to $112.00 and set an “overweight” rating on the stock in a research report on Thursday. Finally, Raymond James Financial set a $103.00 price target on CVS Health in a report on Friday, November 6th. Twenty-three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $107.79.

CVS Health Price Performance

CVS stock opened at $89.69 on Friday. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The company has a current ratio of 0.85, a quick ratio of 0.66 and a debt-to-equity ratio of 0.71. The company has a 50-day moving average price of $89.81 and a 200 day moving average price of $89.00. The stock has a market cap of $114.76 billion, a PE ratio of 10.44, a P/E/G ratio of 0.78 and a beta of 0.58.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, beating the consensus estimate of $1.65 by $0.44. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The company had revenue of $108.40 billion for the quarter, compared to the consensus estimate of $104.72 billion. During the same period in the prior year, the firm posted $1.60 EPS. The firm’s revenue was up 5.4% compared to the same quarter last year. Equities research analysts anticipate that CVS Health Corporation will post 8.26 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were paid a dividend of $0.6650 per share. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.0%. CVS Health’s dividend payout ratio is currently 30.97%.

Insider Activity at CVS Health

In other CVS Health news, EVP Prem Shah purchased 23,855 shares of CVS Health stock in a transaction dated Friday, November 6th. The shares were purchased at an average cost of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the acquisition, the executive vice president owned 88,516 shares in the company, valued at $7,425,607.24. This represents a 36.89% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.85% of the company’s stock.

CVS Health Company Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.